JDVCX
Price
$15.77
Change
-$0.14 (-0.88%)
Updated
Jun 13 closing price
Net Assets
467.49M
RLBCX
Price
$35.41
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

JDVCX vs RLBCX

Header iconJDVCX vs RLBCX Comparison
Open Charts JDVCX vs RLBCXBanner chart's image
JPMorgan Diversified C
Price$15.77
Change-$0.14 (-0.88%)
VolumeN/A
Net Assets467.49M
American Funds American Balanced R3
Price$35.41
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
JDVCX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDVCX vs. RLBCX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVCX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 244B vs. JDVCX (467M). JDVCX pays higher dividends than RLBCX: JDVCX (1.81) vs RLBCX (1.63). JDVCX was incepted earlier than RLBCX: JDVCX (22 years) vs RLBCX (23 years). JDVCX (1.74) is less costly to investors than RLBCX (0.89). JDVCX is a more actively managed with annual turnover of: 63.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JDVCX: RLBCX (250) vs JDVCX (1000). RLBCX (4.94) and JDVCX (4.94) have marching annual gain over last year. RLBCX return over 5 years is better than : 36.51 vs. JDVCX (8.82).
JDVCXRLBCXJDVCX / RLBCX
Total Expense Ratio1.460.89164%
Annual Report Gross Expense Ratio1.740.89196%
Fund Existence22 years23 years-
Gain YTD3.8504.29490%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets467M244B0%
Annual Yield % from dividends1.811.63110%
Returns for 1 year4.944.94100%
Returns for 3 years21.9731.5470%
Returns for 5 years8.8236.5124%
Returns for 10 years4.5154.998%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
NOVA0.22N/A
N/A
Sunnova Energy International
XTNT0.62-0.03
-4.23%
Xtant Medical Holdings
FND73.63-3.40
-4.41%
Floor & Decor Holdings
EZGO0.36-0.02
-4.65%
EZGO Technologies Ltd